Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duncavage

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Cancer Genetics|March 6, 2026
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursorsFelicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Leukemia|October 15, 2016
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapyG L Uy, E J Duncavage, G S Chang, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Cancer Genetics|March 6, 2026
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursorsFelicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Leukemia|October 15, 2016
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapyG L Uy, E J Duncavage, G S Chang, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Pageof 11